Vancouver firm eyes pot treatment
A Vancouver firm is trying to turn marijuana into eyedrops to treat glaucoma. (FILE PHOTO)
A Vancouver-based research and development firm expects to start testing marijuana-derived eyedrops that can treat glaucoma on humans next year.
Cannabis Technologies Inc. president and CEO Craig Schneider said on Tuesday his company has received preliminary approval from the federal government to proceed after successful tests on animals.
He said the aim is to remove the smoking component from marijuana-based medicine.
The clinical trial is expected to take place overseas in China or India.
Schneider said the product, which the company says has no dependency side effects and won’t get patients “high,” could be commercialized by 2018.
“If a patient has MS or arthritis, they shouldn’t be smoking to get their relief,” he said.
“They should be taking a standardized, batch-by-batch product that’s approved through other processes.”